STIM beat EPS expectations by 8.09%
Mar 17, 2026, 10:34 PM
0.00%
What does STIM do
Neuronetics, based in Malvern, Pennsylvania, develops the NeuroStar Advanced Therapy System, a TMS device for treating major depressive disorder. The company went public on June 28, 2018, and employs 202 people.
Neuronetics (STIM) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Neuronetics's actual EPS was -$0.10, beating the estimate of -$0.11 per share, resulting in a 8.09% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.